PharmaEssentia Corporation (LUX:261280523)
Luxembourg · Delayed Price · Currency is EUR · Price in USD 16.10
-0.10 (-0.62%)
At close: Nov 10, 2025
PharmaEssentia Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 4,804 | 2,966 | -623.84 | -1,375 | -2,811 | -1,948 | Upgrade |
Depreciation & Amortization | 344.75 | 336.99 | 250.58 | 225.38 | 226 | 174.03 | Upgrade |
Other Amortization | 43.6 | 30.72 | 18.18 | 2.54 | 1.09 | 0.76 | Upgrade |
Loss (Gain) From Sale of Assets | 1.12 | 0.93 | - | 0.1 | 0.07 | -0.02 | Upgrade |
Stock-Based Compensation | 84.21 | 164.39 | 710.21 | 216.21 | 501.52 | 53.76 | Upgrade |
Other Operating Activities | -1,316 | -253.41 | -383.62 | -464.93 | 11.18 | -0.33 | Upgrade |
Change in Accounts Receivable | -1,403 | -1,312 | -513.66 | -332.6 | -15.45 | 62.49 | Upgrade |
Change in Inventory | 63.17 | 25.34 | -356.61 | -240.66 | -466.53 | -137.52 | Upgrade |
Change in Accounts Payable | 68.45 | -2.44 | -102.05 | 54.62 | -0.69 | 21.89 | Upgrade |
Change in Unearned Revenue | - | 0.23 | - | - | - | -0.07 | Upgrade |
Change in Other Net Operating Assets | 1,622 | 590.17 | 291.29 | 408.68 | 91.74 | 317.86 | Upgrade |
Operating Cash Flow | 4,315 | 2,547 | -709.51 | -1,505 | -2,462 | -1,455 | Upgrade |
Capital Expenditures | -1,290 | -862 | -1,286 | -312.03 | -70.33 | -81.16 | Upgrade |
Sale of Property, Plant & Equipment | - | - | - | - | - | 0.23 | Upgrade |
Cash Acquisitions | - | - | - | - | - | -1.73 | Upgrade |
Sale (Purchase) of Intangibles | -40.53 | -41.49 | -41.65 | -8.72 | -27.54 | -126.36 | Upgrade |
Investment in Securities | -883 | -421.23 | -96 | - | -25 | -71.05 | Upgrade |
Other Investing Activities | -14.69 | -10.17 | 937.04 | -922.07 | 44.7 | -22.14 | Upgrade |
Investing Cash Flow | -2,228 | -1,335 | -486.65 | -1,243 | -78.18 | -302.2 | Upgrade |
Short-Term Debt Issued | - | - | 1 | 973.88 | - | 50 | Upgrade |
Long-Term Debt Issued | - | - | - | - | - | 25 | Upgrade |
Total Debt Issued | 2,175 | - | 1 | 973.88 | - | 75 | Upgrade |
Short-Term Debt Repaid | - | -21 | -973.88 | - | -30 | - | Upgrade |
Long-Term Debt Repaid | - | -233.12 | -150.97 | -127.41 | -116.23 | -86.71 | Upgrade |
Total Debt Repaid | -2,407 | -254.12 | -1,125 | -127.41 | -146.23 | -86.71 | Upgrade |
Net Debt Issued (Repaid) | -232.36 | -254.12 | -1,124 | 846.47 | -146.23 | -11.71 | Upgrade |
Issuance of Common Stock | 111.38 | 91.1 | 14,330 | 8,743 | 3,045 | 3,837 | Upgrade |
Repurchase of Common Stock | - | - | -2,718 | - | -87.5 | -257.24 | Upgrade |
Other Financing Activities | -22.19 | -22.19 | -34.56 | -10.26 | -2.41 | -1.42 | Upgrade |
Financing Cash Flow | -509.35 | -185.21 | 10,454 | 9,579 | 2,809 | 3,566 | Upgrade |
Foreign Exchange Rate Adjustments | -828.48 | 358.27 | 104.11 | 19 | -15.25 | -4.19 | Upgrade |
Net Cash Flow | 749.32 | 1,385 | 9,362 | 6,850 | 253.27 | 1,805 | Upgrade |
Free Cash Flow | 3,025 | 1,685 | -1,996 | -1,818 | -2,532 | -1,536 | Upgrade |
Free Cash Flow Margin | 21.90% | 17.31% | -39.09% | -63.06% | -385.74% | -275.72% | Upgrade |
Free Cash Flow Per Share | 8.15 | 4.54 | -5.58 | -5.76 | -8.77 | -5.71 | Upgrade |
Cash Interest Paid | 25.07 | 22.19 | 34.56 | 10.26 | 2.41 | 1.42 | Upgrade |
Cash Income Tax Paid | 347.99 | 297.9 | 76.87 | 5.68 | -0 | 1.78 | Upgrade |
Levered Free Cash Flow | 2,091 | 21.42 | -1,292 | -2,589 | -1,316 | -803.94 | Upgrade |
Unlevered Free Cash Flow | 2,107 | 35.29 | -1,263 | -2,577 | -1,310 | -798.78 | Upgrade |
Change in Working Capital | 350.7 | -698.22 | -681.02 | -109.97 | -390.93 | 264.66 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.